NysnoBio ia dedicated to developing the therapeutic potential of the Parkin protein for patients with serious medical conditions. We envision a future where the power of the Parkin pathway is directed toward specific disease areas, where the activation of the repair pathway can have maximum therapeutic benefits. Our core team of industry professionals and network of academic experts are working together to deliver on the scope of therapeutic potential for Parkin cellular repair.
| Website | http://nysnobio.com |
| Employees | 6 (5 on RocketReach) |
| Founded | 2019 |
| Address | 650 E Blithedale Ave, Mill Valley, California 94941, US |
| Industry | Biotechnology Research |
| Keywords | Therapeutic Drug Development, Biotechnology, Pharmaceutical Research, Drug Discovery, Disease Treatment, Medical Research, Protein Science, Biomedical Research, Genetic Disorders, Clinical Trials, New Therapies, Health Innovation, Life Sciences, Molecular Biology, Biopharmaceutical, Precision Medicine |
| Competitors | Roche, Thermo Fisher Scientific, BD, Agilent Technologies, Illumina, Lonza, QIAGEN, 10x Genomics, PacBio +36 more (view full list) |
Looking for a particular NysnoBio employee's phone or email?
Vit Vasista is the CFO of NysnoBio.
5 people are employed at NysnoBio.
NysnoBio is based in Mill Valley, California.